Killian Meara

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences, discuses the benefits of glucagon.

A study found that patients with medication-overuse headache and neck pain experience earlier onset of primary headache and decreased quality of life.

A conversation with Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, professor of pharmacy practice at Massachusetts College of Pharmacy and Health Sciences.

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

Authors concluded that that the benefit of the vaccine in preventing long COVID is due mainly to the fact it mitigates the risk of infection.

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses key risk factors for hypoglycemia and what education programs should emphasize so people with diabetes and their caregivers can improve its management.

A conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia, on RSV vaccine recommendations.

MannKind announced results from the INHALE-1 study that examined Afrezza in children and adolescents with diabetes.

Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses her career and how biosimilars will impact the pharmacy profession in the coming years.

Student pharmacists who wore a continuous glucose monitor had a higher average counseling score during an encounter with a patient and a higher overall confidence score.

A conversation with Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic.

Two posters presented at the meeting looked into the topic CGMs in diabetes care.

Vtama from Organon was previously approved in May 2022 to treat plaque psoriasis in adults.

A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.

A conversation with Julia L. Ziegengeist, PharmD, BCOP, clinical pharmacist coordinator of breast medical oncology for the Levine Cancer Institute at Atrium Health.

Nina Vadiei, PharmD, BCPP, discusses some of the challenges she faces working with forensic patients who have been charged with a crime and have severe mental illness.

A conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia.

Research found that SGLT2 inhibitors were associated with a lower risk of major cardiovascular events or hospitalization for heart failure.

Ethan Melillo, PharmD, CDOE, senior manager of Integrated Health at L’Oréal, provides some of his favorite recommendations to help with irritated skin.

A conversation with Kathleen Vest, PharmD, BCACP, CDCES, FCCP, professor of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences.

The effectiveness of remdesivir was consistent among patients who received any form of supplemental oxygen and across all age groups in the study.

Medication alerts, nurse education, and pharmacist interventions led to lower hypoglycemic events every year after they were implemented.

A conversation with Madison Irwin, PharmD, BCPS, clinical pharmacist specialist in palliative care at University of Michigan Health and a clinical assistant professor at the University of Michigan College of Pharmacy.

Research also showed that the percentage of no-show appointments was slightly higher in a pre-virtual group compared to a post-virtual group.

A discussion with Kevin Cowart, PharmD, MPH, BCACP, FCCP, BCPS, assistant professor at the University of South Florida Taneja College of Pharmacy.

A discussion with Brittany Norton, PharmD, director of ambulatory care at Sutter Health.

Catch up on important FDA news from the week of December 2.

Madison Irwin, PharmD, BCPS, discusses her career pharmacy and how she thinks high rates of chronic pain will impact the field in the coming years.

A recent study found that patients who consumed 5 or more servings a week of dark chocolate had a significantly lower rate of type 2 diabetes.

The MOVe-NOW study will assess the investigational oral antiviral using a different formulation than what is currently approved under an emergency use authorization.